Mirasol® — Pathogen inactivation system
Terumo BCT

Mirasol® — Pathogen inactivation system


Short description

Mirasol is a system for inactivating pathogens in blood products designed to enhance the safety of blood components and reduce the risk of transmission of infectious agents. The technology is based on the use of a photoactivatable reagent together with visible light, which effectively reduces the infectious potential of viruses, bacteria and parasites in plasma and platelets, while maintaining the functional qualities of the components.

The Mirasol system is designed for blood centers and transfusion services seeking to improve the safety standards of transfusion medicine.

Scope of application

  • Blood Centers
  • Transfusiology Services
  • Clinical and diagnostic institutions
  • Medical laboratories for processing blood components

Purpose and functions performed

Mirasol is designed to inactivate a wide range of pathogens in blood products, including:

  • viruses;
  • bacteria;
  • parasites;
  • potentially present microorganisms.

The system is applied to plasma and platelets, reducing the risk of infection during transfusions and protecting the recipient.


Key advantages

  • Effective reduction of the infectious potential of pathogens
  • Improving plasma and platelet safety
  • Preservation of functional properties of blood components
  • Improved preparation of components for clinical use
  • Integration into transfusion medicine processes

Technological features

Reagent photoactivation

  • Using a photoactivatable reagent in combination with visible light to inactivate pathogens.
  • The technology allows to affect a wide range of viruses, bacteria and other microorganisms.

Maintaining the quality of components

  • The process is aimed at reducing the risk of infection while maintaining the functionality of plasma and platelets.
  • Optimized treatment conditions for minimal impact on the target blood components.

Security and integration

  • Easy integration into existing blood component processing streams in blood centers and transfusion services.
  • Ease of operation and process control.

Who is it intended for

  • Blood centers and transfusion stations
  • Clinical Transfusiology Services
  • Laboratories for processing blood components
  • Medical institutions focused on improving safety standards

Compliance with standards

  • Supports the requirements of transfusion medicine for safety and quality control
  • Meets modern requirements for inactivation of pathogens in blood components


Documentation